Scripps serves as a prime example that it should not be assumed that when a biotech institute expands, they are planning on duplicating the research they are currently conducting at existing facilities.
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Got It!," you consent to our use of cookies.